Spectral Medical Inc. (SD4)
XSTU 
Summary
SD4 Chart
Spectral Medical Inc. (SD4) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Spectral Medical Inc. ever had a stock split?
Spectral Medical Inc. Profile
| Professional Services Industry | Industrials Sector | Mr. Christopher Seto CEO | XSTU Exchange | CA8475771033 ISIN |
| CA Country | 29 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Spectral Medical Inc. is a pioneer in the development and commercialization of innovative treatment solutions for septic shock, with its operations extending across the United States, Italy, Ireland, and other international markets. Established in 1991 and originally known as Spectral Diagnostics Inc., the company underwent a name change to Spectral Medical Inc. in December 2014, reflecting a broader focus on medical solutions beyond diagnostics. Headquartered in Toronto, Canada, Spectral Medical Inc. is dedicated to combating septic shock, a serious medical condition that poses significant treatment challenges worldwide.
Products and Services
- Endotoxin Activity Assay
A unique diagnostic tool, the Endotoxin Activity Assay (EAA) serves as a rapid in vitro test designed to detect components of the gram-negative bacterial cell wall. By identifying the presence of endotoxins, which are often a precursor to septic shock, this assay allows healthcare providers to rapidly diagnose and initiate treatment, potentially saving lives through early intervention.
- Polymyxin B Hemoperfusion
This therapeutic device represents a significant advancement in the treatment of septic shock. Through the process of hemoperfusion, it effectively removes endotoxins from the bloodstream. By directly addressing the source of the problem, Polymyxin B Hemoperfusion has the potential to significantly improve patient outcomes in cases of severe infection.
- Biological Components Development
Spectral Medical Inc. not only delivers finished medical devices but also focuses on the development and manufacturing of key biological components that play a crucial role in the medical diagnostics field. This includes the creation of monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators. These components are essential for research and development within the medical community, as well as for the production of diagnostics by other companies in the industry. Through this multifaceted approach, Spectral Medical Inc. contributes widely to advancements in diagnostic technologies and treatments.
Contact Information
